- US-listed companies
- Cyclo Therapeutics, Inc.
- Balance sheet
Cyclo Therapeutics, Inc. (CYTH) Balance sheet
Market cap
$20.73M
P/E ratio
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Cash and cash equivalents | 1,270,973 | 2,217,412 | 2,783,719 | 12,846,113 | 16,612,711 | 1,543,418 | 9 |
| Total cash & short-term investments | 1,270,973 | 2,217,412 | 2,783,719 | 12,846,113 | 16,612,711 | 1,543,418 | 9 |
| Accounts receivable, net | 56,860 | 80,044 | 143,429 | 71,017 | 493,113 | 54,991 | 122,379 |
| Inventories | 471,221 | 416,531 | 242,630 | 237,909 | 227,437 | 254,491 | 254,352 |
| Total current assets | 1,895,784 | 2,769,611 | 3,958,069 | 14,050,237 | 19,436,335 | 4,158,555 | 12 |
| Property, plant and equipment, net | 25,736 | 18,571 | 13,546 | 53,910 | 59,583 | 55,188 | 38,332 |
| Total assets | 2,088,648 | 2,917,856 | 4,113,228 | 14,187,964 | 19,520,833 | 4,215,213 | 13 |
| Total current liabilities | - | - | 3,141,120 | 3,672,553 | 3,830,936 | 3,480,669 | 8 |
| Total non-current liabilities | - | - | - | 62,929 | 18,034 | - | 22,484 |
| Retained earnings | -13,332,667 | -17,587,700 | -25,120,233 | -34,061,836 | -48,348,491 | -63,799,379 | -83,856,681 |
| Stockholders' equity | 1,145,618 | 992,524 | 935,982 | 10,452,482 | 15,671,863 | 734,544 | 5 |